Mycroft has officially emerged from stealth and announced the raising of US $3.5 million in seed funding. The financing was led by Luge Capital, with participation from Brightspark Ventures, Graphite ...

Agentic artificial intelligence security startup Mycroft Technologies Inc. launched today and announced that it has raised $3.5 million in funding to accelerate product development and expand its ...

The Canada-based company has emerged from stealth with autonomous AI agents designed to manage and operate the security and IT stack. Toronto, Canada-based company Mycroft emerged from stealth on ...

Toronto-based startup hopes to become leading AI platform for photocatalyst discovery. A little sunlight, and a little photocatalytic powder. That’s all Toronto-based cleantech startup Xatoms says it ...

MONTREAL — Dispersa, a Canadian cleantech startup turning food waste into sustainable chemical ingredients, announces the successful close of $5.8 million CAD in seed funding. The round was led by ...

The funds will also enable the development of next generation compounds, according to the company. Axonis Therapeutics, which operates in the US, has announced $115m in Series A financing to progress ...

Sagard-backed firm will apply FinTech-honed venture builder model to cleantech. Montréal-based venture builder and investor Diagram Ventures has fuelled up to expand beyond its FinTech roots with the ...

The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable ...

Seattle-based Talus Bioscience has raised $11.2 million in an early fundraising round, money that will go toward advancing the biotech’s portfolio of preclinical cancer programs and help build out the ...

Talus Bioscience on Tuesday announced $11.2 million in venture capital funding to advance its drug discovery program for hard-to-treat diseases. The Seattle biotech’s platform brings biochemical ...

Talus Bioscience was founded to discover molecules that target transcription factors (TFs), or proteins that regulate the genome by binding to DNA and orchestrating which genes are turned on or off at ...

BOULDER — Boulder life-sciences startup BioLoomics Inc. has appointed Kurt Gish as the company’s chief scientific officer. Bioloomics develops targeted therapeutics for tumors. Gish will focus on ...